Kim, D.; Kim, J.M.; Kim, J.-S.; Kim, S.; Kim, K.-H.
Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder. J. Clin. Med. 2020, 9, 1265.
https://doi.org/10.3390/jcm9051265
AMA Style
Kim D, Kim JM, Kim J-S, Kim S, Kim K-H.
Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder. Journal of Clinical Medicine. 2020; 9(5):1265.
https://doi.org/10.3390/jcm9051265
Chicago/Turabian Style
Kim, Donghyun, Jin Man Kim, Jun-Sang Kim, Sup Kim, and Kyung-Hee Kim.
2020. "Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder" Journal of Clinical Medicine 9, no. 5: 1265.
https://doi.org/10.3390/jcm9051265
APA Style
Kim, D., Kim, J. M., Kim, J.-S., Kim, S., & Kim, K.-H.
(2020). Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder. Journal of Clinical Medicine, 9(5), 1265.
https://doi.org/10.3390/jcm9051265